| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |